Autoradiographic evidence for differential G-protein coupling of 5- HT(1A) receptors in rat brain: Lack of effect of repeated injections of fluoxetine

Brain Research

Volumn 769, Issue 1, 1997, Pages 141-151

  Li, Qian ^a   Battaglia, George ^a   Van De Kar, Louis D ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

5 HT uptake inhibitor; 8 OH DPAT binding; Antidepressant; Gpp(NH)P; Hypothalamus; Receptor coupling; Serotonin; SSRI

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; FLUOXETINE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANYLYLIMIDODIPHOSPHATE; SEROTONIN 1A RECEPTOR;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CONTROLLED STUDY; HYPOTHALAMUS; ISOTOPE LABELING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; TISSUE DISTRIBUTION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; AUTORADIOGRAPHY; BRAIN; FLUOXETINE; GTP-BINDING PROTEINS; GUANYLYL IMIDODIPHOSPHATE; HYPOTHALAMUS; INJECTIONS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 0030723373     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00693-8     Document Type: Article

References (82)

1. Adell A., Carceller A., Artigas F. In vivo brain dialysis study of the somatodendritic release of serotonin in the raphe nuclei of the rat: Effects of 8-hydroxy-2-(di-n-propylamino)tetralin. J. Neurochem. 60:1993;1673-1681.
2. Advokat C., Kutlesic V. Pharmacotherapy of the eating disorders: A commentary. Neurosci. Biobehav. Rev. 19:1995;59-66.
3. 1A receptor: Signaling, desensitization, and gene transcription. Neuropsychopharmacology. 14:1996;19-25.
4. 1A agonist 8-OH-DPAT in conscious rats. Brain Res. 716:1996;224-228.
5. Artigas F. 5-HT and antidepressants: new views from microdialysis studies. Trends Pharmacol. Sci. 14:1993;262.
6. 1C receptors induce oxytocin release in the male rat. Brain Res. 611:1993;330-332.
7. 2 receptor agonist-induced oxytocin, prolactin, and corticosterone responses. Endocrinology. 134:1994;1127-1131.
8. Bertin B., Freissmuth M., Breyer R.M., Schütz W., Strosberg A.D., Marullo S. Functional expression of the human serotonin 5-HT1A receptor in Escherichia coli. Ligand binding properties and interaction with recombinant G protein α-subunits. J. Biol. Chem. 267:1992;8200-8206.
9. Blier P., de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15:1994;220-226.
10. Briley M., Moret C. Neurobiological mechanisms involved in antidepressant therapies. Clin. Neuropharmacol. 16:1993;387-400.
11. Brownfield M.S., Greathouse J., Lorens S.A., Armstrong J., Urban J.H., Van de Kar L.D. Neuropharmacological characterization of serotoninergic stimulation of vasopressin secretion in conscious rats. Neuroendocrinology. 47:1988;277-283.
12. 1A receptor messenger ribonucleic acid abundance and serotonin levels parallel the activity of the hypothalamo-pituitary-adrenal axis in rats. Behav. Brain Res. 73:1995;365-368.
13. Burnet P.W.J., Michelson D., Smith M.A., Gold P.W., Sternberg E.M. The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptors and the abundancies of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat. Brain Res. 638:1994;311-324.
14. 1A receptor in Sf9 cells. Reconstitution of a coupled phenotype by co-expression of mammalian G protein subunits. J. Biol. Chem. 270:1995;18691-18699.
15. 3H]8-OH-DPAT) binding. J. Pharmacol. Exp. Ther. 266:1993;618-625.
16. Coirini H., Johnson A.E., Schumacher M., McEwen B.S. Sex differences in the regulation of oxytocin receptors by ovarian steroids in the ventromedial hypothalamus of the rat. Neuroendocrinology. 55:1992;269-275.
17. 1A agonists. Synapse. 14:1993;297-304.
18. 1A receptor antagonist WAY100635. Eur. J. Pharmacol. 264:1994;95-97.
19. Cunningham E.T. Jr., Sawchenko P.E. Reflex control of magnocellular vasopressin and oxytocin secretion. Trends Neurosci. 14:1991;406-411.
20. 1A receptor agonists: Recent developments and controversial issues. Psychopharmacology (Berl.). 121:1995;1-26.
21. DonCarlos L.L., Monroy E., Morrell J.I. Distribution of estrogen receptor-immunoreactive cells in the forebrain of the female guinea pig. J. Comp. Neurol. 305:1991;591-612.
22. 1A agonists 8-OH-DPAT and gepirone. Methods Find. Exp. Clin. Pharmacol. 16:1994;91-96.
23. 1A receptor. J. Neurochem. 56:1991;1705-1716.
24. 1A receptor binding sites following chronic treatment with ipsapirone measured by quantitative autoradiography. Synapse. 12:1992;75-81.
25. 1A receptor antagonist. Behav. Brain Res. 73:1996;337-353.
26. Frankfurt M., Mckittrick C.R., Mendelson S.D., McEwen B.S. Effect of 5,7-dihydroxytryptamine, ovariectomy and gonadal steroids on serotonin receptor binding in rat brain. Neuroendocrinology. 59:1994;245-250.
27. Frankfurt M., Mendelson S.D., Mckittrick C.R., McEwen B.S. Alterations of serotonin receptor binding in the hypothalamus following acute denervation. Brain Res. 601:1993;349-352.
28. 1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: Recent findings from in vivo microdialysis studies. Fundam. Clin. Pharmacol. 10:1996;16-27.
29. 1A receptor. Biochemistry. 33:1994;4283-4290.
30. 1A receptor subtype increases rat plasma ACTH concentration. Eur. J. Pharmacol. 147:1988;431-439.
31. 1A receptors in rat brain membranes. Eur. J. Pharmacol. Mol. Pharmacol. 288:1995;173-186.
32. 1A receptor regulation: Effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology. 4:1991;131-144.
33. Hoyer D., Boddeke H.W.G.M. Partial agonists, full agonists, antagonists: dilemmas of definition. Trends Pharmacol. Sci. 14:1993;270-274.
34. Hutson P.H., Sarna G.S., O'Connell M.T., Curzon G. Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OH-DPAT into the nucleus raphe dorsalis. Neurosci. Lett. 100:1989;276-280.
35. 1A receptors in bovine brain. Br. J. Pharmacol. 113:1994;1400-1406.
36. B-induced hyperpolarization of rat dorsal raphe neurons. Brain Res. 459:1988;27-36.
37. Kawano S., Osaka T., Kannan H., Yamashita H. Excitation of hypothalamic paraventricular neurons by stimulation of the raphe nuclei. Brain Res. Bull. 28:1992;573-579.
38. 1A receptor antagonist. Brain Res. 673:1995;217-225.
39. 1A receptors in the rat central nervous system. J. Comp. Neurol. 365:1996;289-305.
40. 2A serotonin receptors in the brain of rats and mice hereditarily predisposed to catalepsy. Pharmacol. Biochem. Behav. 50:1995;383-387.
41. Lam R.W., Gorman C.P., Michalon M., Steiner M., Levitt A.J., Corral M.R., Watson G.D., Morehouse R.L., Tam W., Joffe R.T. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. Am. J. Psychiatry. 152:1995;1765-1770.
42. 1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedebergs Arch. Pharmacol. 352:1995;141-148.
43. Y. Lecrubier, Antidepressant drugs: similar but different?, in: J. Mendlewicz, N. Brunello, S.Z. Lnger, G. Racagni (Eds.), New Pharmacological Approaches to the Therapy of Depressive Disorders, Karger, Basel, 1993, pp. 83-91.
44. Lefkowitz R.J., Mullikin D., Caron M.G. Regulation of beta-adrenergic receptors by guanyl-5′-yl imidodiphosphate and other purine nucleotides. J. Biol. Chem. 251:1976;4686-4692.
45. 1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats. Biol. Psychiatry. 36:1994;300-308.
46. 1A agonist 8-OH-DPAT in male rats. Brain Res. 630:1993;148-156.
47. 1A agonist. J. Pharmacol. Exp. Ther. 279:1996;1035-1042.
48. Liposits Z., Phelix C., Paull W.K. Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study. Histochemistry. 86:1987;541-549.
49. 1A receptor-mediated regulation of plasma neuroendocrine hormones. J. Pharmacol. Exp. Ther. 271:1994;1246-1252.
50. 1A Receptors: Differential involvement in female and male sexual behavior in the rat. Physiol. Behav. 37:1986;345-351.
51. 1A receptor in rat hippocampus. Brain Res. 590:1992;229-238.
52. Montgomery S.A. Antidepressants in long-term treatment. Annu. Rev. Med. 45:1994;447-457.
53. Mulheron J.G., Casanas S.J., Arthur J.M., Garnovskaya M.N., Gettys T.W., Raymond J.R. Human 5-HT1A receptor expressed in insect cells activates endogenous G(o)-like G protein(s). J. Biol. Chem. 269:1994;12954-12962.
54. 3H]8-OH-DPAT binding sites in rat cerebral cortex and hippocampus. Neurochem. Res. 21:1996;167-176.
55. 1A receptors activate a potassium conductance in rat ventromedial hypothalamic neurones. Eur. J. Pharmacol. 210:1992;209-212.
56. 3H]hydroxydipropylaminotetralin. J. Neurochem. 62:1994;1822-1834.
57. 1A receptors, VCH, New York, 1987, pp. 67-81.
58. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, Sydney, Australia, 1986.
59. Pazos A., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. Brain Res. 346:1985;205-230.
60. Pinto W., Battaglia G. Comparative recovery kinetics of 5-hydroxytryptamine 1A, 1B, and 2A receptor subtypes in rat cortex after receptor inactivation: Evidence for differences in receptor production and degradation. Mol. Pharmacol. 46:1994;1111-1119.
61. 1A receptor in the rat brain: Correlation with receptor binding. J. Neurosci. 12:1992;440-453.
62. 1A receptor binding sites in the rat brain: A quantitative autoradiographic study. J. Neurochem. 58:1992;1338-1346.
63. sα. Biochemistry. 32:1993;11064-11073.
64. Richelson E. Biological basis of depression and therapeutic relevance. J. Clin. Psychiatry. 52((Suppl. 6)):1991;4-10.
65. 1A receptors. Brain Res. 532:1990;191-196.
66. Saphier D. Paraventricular nucleus magnocellular neuronal responses following electrical stimulation of the midbrain dorsal raphe. Exp. Brain Res. 85:1991;359-363.
67. Sawchenko P.E., Swanson L.W., Steinbusch H.W.M., Verhofstad A.A.J. The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat. Brain Res. 277:1983;355-360.
68. Simerly R.B., Chang C., Muramatsu M., Swanson L.W. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J. Comp. Neurol. 294:1990;76-95.
69. R.G.D. Steel, J.H. Torrie, Principles and Procedures of Statistics with Special Reference to the Biological Sciences, McGraw-Hill, New York, 1960.
70. Sternlicht H.C. Obsessive-compulsive disorder, fluoxetine and buspirone. Am. J. Psychiatry. 150:1993;526.
71. 2 receptor subtypes. Mol. Pharmacol. 38:1990;594-598.
72. 1A receptor activation in vivo. Life Sci. 56:1995;PL163-PL168.
73. Tollefson G.D., Rampey A.H. Jr., Potvin J.H., Jenike M.A., Rush A.J., Dominguez R.A., Koran L.M., Shear M.K., Goodman W., Genduso L.A. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch. Gen. Psychiatry. 51:1994;559-567.
74. 1A agonist, 8-OH-DPAT, on lordosis behavior. Pharmacol. Biochem. Behav. 47:1994;467-470.
75. 1A agonist in the VMN. Brain Res. 637:1994;173-180.
76. Van de Kar L.D., Brownfield M.S. Serotonergic neurons and neuroendocrine function. News Pharmacol. Sci. 8:1993;202-207.
77. Van Wijngaarden I., Tulp M.T.M., Soudijn W. The concept of selectivity in 5-HT receptor research. Eur. J. Pharmacol. 188:1990;301-312.
78. 1A antagonist WAY-100635 inhibits the 8-OH-DPAT induced increase in plasma ACTH, corticosterone and oxytocin but not prolactin. Soc. Neurosci. Abstr. 22:1996;1326. (527.3).
79. 3H]8-hydroxy-N,N-dipropyl-2-aminotetralin serotonergic binding site in Alzheimer's disease. Behav. Brain Res. 73:1995;325-329.
80. Wong D.T., Bymaster F.P., Engleman E.A. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication. Life Sci. 57:1995;411-441.
81. 2 receptor subtype mRNAs in rat brain. J. Comp. Neurol. 351:1995;357-373.
82. K. Zilles, The Cortex of the Rat, A Stereotaxic Atlas, Springer, Berlin, 1985.